Hyphenated Systems Announces Joint Development Program with University of California Santa Barbara
News Feb 21, 2007
Hyphenated Systems has announced a joint development program (JDP) with the University of California, Santa Barbara (UCSB). Under the agreement, Hyphenated Systems will make available one of its 3D MAP™ (Microfluidics Analysis Platform) tools to Professor Meinhart’s research group at the Microfluidics Laboratory for use in investigating the fundamental relationships between structure and flow in microfluidic devices.
3D MAP uses advanced confocal microscopy to visualize and measure 3D structure and flow with sub-micrometer resolution. The system has ability to provide structural characterization of all aspects of microfluidic devices that are difficult or impossible to measure with alternative techniques.
Dr. Carl Meinhart, Associate Professor at the UCSB Department of Mechanical Engineering says, “Our research includes developing micron-resolution particle image velocimetry (micro-PIV), ac electrokinetic devices for concentrating DNA & enhancing immunoassay reactions, and investigating structure/fluid interactions in biological cells.
The 3D MAP from Hyphenated Systems will be help us gain an understanding of the dynamic behavior of fluids and their interactions with solid structures in microfluidic devices.”
Terence Lundy, Vice President and Managing Director of Hyphenated Systems adds, “The field of microfluidics is in its infancy and there is still a lot of research and development to be done. It is our mission to provide the tools that researchers and engineers need to develop a fundamental understanding of microfluidic phenomena and convert that knowledge into commercial products. We are pleased to have the opportunity to support Dr. Meinhart’s pioneering work in microfluidics.”
Instead of searching for a needle in a haystack, what if you were able to sweep the entire haystack to one side, leaving only the needle behind? That's the strategy researchers followed in developing a new microfluidic device that separates elusive circulating tumor cells (CTCs) from a sample of whole blood.READ MORE